Development and validation of a novel 10-year residual risk score (RRS) in the UK Biobank and Massachusetts General Brigham populations for patients with established ASCVD
Please note:
This action will also remove this member from your connections and send a report to the site admin.
Please allow a few minutes for this process to complete.